191 related articles for article (PubMed ID: 3359114)
1. Relative affinities of drugs acting at cholinoceptors in displacing agonist and antagonist radioligands: the NMS/Oxo-M ratio as an index of efficacy at cortical muscarinic receptors.
Freedman SB; Harley EA; Iversen LL
Br J Pharmacol; 1988 Feb; 93(2):437-45. PubMed ID: 3359114
[TBL] [Abstract][Full Text] [Related]
2. Affinities of muscarinic drugs for [3H]N-methylscopolamine (NMS) and [3H]oxotremorine (OXO) binding to a mixture of M1-M4 muscarinic receptors: use of NMS/OXO-M ratios to group compounds into potential agonist, partial agonist, and antagonist classes.
Sharif NA; Williams GW; DeSantis LM
Neurochem Res; 1995 Jun; 20(6):669-74. PubMed ID: 7566362
[TBL] [Abstract][Full Text] [Related]
3. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
Gillard M; Waelbroeck M; Christophe J
Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of an agonist index: affinity ratio for compounds active on muscarinic cholinergic M2 receptors.
Tayebati SK; Piergentili A; Natale D; Amenta F
J Auton Pharmacol; 1999 Apr; 19(2):77-84. PubMed ID: 10466939
[TBL] [Abstract][Full Text] [Related]
5. L-689,660, a novel cholinomimetic with functional selectivity for M1 and M3 muscarinic receptors.
Hargreaves RJ; McKnight AT; Scholey K; Newberry NR; Street LJ; Hutson PH; Semark JE; Harley EA; Patel S; Freedman SB
Br J Pharmacol; 1992 Oct; 107(2):494-501. PubMed ID: 1422595
[TBL] [Abstract][Full Text] [Related]
6. M2-muscarinic receptors: how does ligand binding affinity relate to intrinsic activity?
Van Gelderen JG; Daeffler L; Scherrer D; Mousli M; Landry Y; Gies JP
J Recept Signal Transduct Res; 1996; 16(1-2):135-48. PubMed ID: 8771535
[TBL] [Abstract][Full Text] [Related]
7. Bretylium tosylate binds preferentially to muscarinic receptors labelled with [3H]oxotremorine M (SH or 'high affinity' receptors) in rat heart and brain cortex.
Gillard M; Brunner F; Waelbroeck M; Svoboda M; Christophe J
Eur J Pharmacol; 1989 Jan; 160(1):117-24. PubMed ID: 2714357
[TBL] [Abstract][Full Text] [Related]
8. Studies of muscarinic receptor reserve linked to phosphoinositide hydrolysis in parotid gland and cerebral cortex.
Ek B; Antonsson BM
Acta Physiol Scand; 1993 Mar; 147(3):289-95. PubMed ID: 8386426
[TBL] [Abstract][Full Text] [Related]
9. Prevention of guanine nucleotide-induced reductions in muscarinic agonist binding to rabbit ileal submucosal membranes by lidamidine and tetracaine.
Bleakman D; Naftalin RJ
Naunyn Schmiedebergs Arch Pharmacol; 1988 Apr; 337(4):366-72. PubMed ID: 2900471
[TBL] [Abstract][Full Text] [Related]
10. Muscarinic toxins from the venom of Dendroaspis snakes with agonist-like actions.
Jerusalinsky D; Kornisiuk E; Bernabeu R; Izquierdo I; Cerveñansky C
Toxicon; 1995 Apr; 33(4):389-97. PubMed ID: 7570625
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of muscarine receptors of PC12 (rat phaeochromocytoma) cells.
Bönisch H; Boer R; Dobler M; Schudt C
Naunyn Schmiedebergs Arch Pharmacol; 1990 Mar; 341(3):158-64. PubMed ID: 2342599
[TBL] [Abstract][Full Text] [Related]
12. Muscarinic receptor coupling to inositol phospholipid metabolism in guinea-pig cerebral cortex, parotid gland and ileal smooth muscle.
Ek B; Nahorski S
Biochem Pharmacol; 1988 Dec; 37(23):4461-7. PubMed ID: 2849446
[TBL] [Abstract][Full Text] [Related]
13. Effects of d-tubocurarine on rat cardiac muscarinic receptors: a comparison with gallamine.
Waelbroeck M; Robberecht P; De Neef P; Christophe J
J Recept Res; 1988; 8(6):787-808. PubMed ID: 3193402
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of quinidine on rat heart muscarinic receptors.
Waelbroeck M; De Neef P; Robberecht P; Christophe J
Life Sci; 1984 Sep; 35(10):1069-76. PubMed ID: 6482646
[TBL] [Abstract][Full Text] [Related]
15. Heparin, dextran and trypan blue allosterically modulate M2 muscarinic receptor binding properties and interfere with receptor-mediated inhibition of adenylate cyclase.
Gerstin EH; Luong T; Ehlert FJ
J Pharmacol Exp Ther; 1992 Dec; 263(3):910-7. PubMed ID: 1281880
[TBL] [Abstract][Full Text] [Related]
16. A novel series of non-quaternary oxadiazoles acting as full agonists at muscarinic receptors.
Freedman SB; Harley EA; Patel S; Newberry NR; Gilbert MJ; McKnight AT; Tang JK; Maguire JJ; Mudunkotuwa NT; Baker R
Br J Pharmacol; 1990 Nov; 101(3):575-80. PubMed ID: 2076477
[TBL] [Abstract][Full Text] [Related]
17. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex.
Ehlert FJ; Jenden DJ
Mol Pharmacol; 1985 Aug; 28(2):107-19. PubMed ID: 3839562
[TBL] [Abstract][Full Text] [Related]
18. In vitro down-regulation predicts agonist efficacy at central muscarinic cholinergic receptors.
Stoll L; Müller WE
Biochem Pharmacol; 1991 Jun; 41(12):1963-6. PubMed ID: 2039547
[TBL] [Abstract][Full Text] [Related]
19. Allosteric site in M2 acetylcholine receptors: evidence for a major conformational change upon binding of an orthosteric agonist instead of an antagonist.
Grossmüller M; Antony J; Tränkle C; Holzgrabe U; Mohr K
Naunyn Schmiedebergs Arch Pharmacol; 2006 Jan; 372(4):267-76. PubMed ID: 16362429
[TBL] [Abstract][Full Text] [Related]
20. Effects of serotonergic denervation on the density and plasticity of brain muscarinic receptors in the rat.
Alonso R; Soubrie P
Synapse; 1991 May; 8(1):30-7. PubMed ID: 1714634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
